Page URL: https://www.bionews.org.uk/page_137604

Japan launches first clinical trial of stem cells for Parkinson's

6 August 2018
Appeared in BioNews 961

A first-of-its-kind clinical trial has been announced, which will use iPS (induced pluripotent stem) cells to treat Parkinson's disease patients.

The trial, led by Professor Jun Takahashi at Kyoto University in Japan, follows on from the successful application of this treatment in a primate model of the disease reported last year (see BioNews 916). Seven patients will be treated with the 'reprogrammed' adult stem cells and followed up for two years, with the primary objective to assess safety and tolerability.

'This will be the world’s first clinical trial using iPS cells on Parkinson's disease,' Professor Takahashi told a news conference last week.

The treatment itself will consist of an injection of 5 million stem cell-derived neural progenitor cells, directly into the brain of patients. The researchers hope that over time, the progenitor cells will mature and engraft into the patients' neural networks and begin to release dopamine, which is the neurotransmitter lost in Parkinson's disease. 

Typically, the loss of dopaminergic neurons in Parkinson's disease causes patients to have difficulty initiating movement and sees them develop a consistent baseline tremor, both of which are very debilitating.

The stem cells used in these treatments will come from healthy third-party donor blood cells which are prepared and banked at the iPS Cell Stock for Regenerative Medicine. Although this carries a risk of transplant rejection, the researchers state that 'using stocks of cells, we can proceed much more quickly and cost-effectively'. The patients will also be treated with a common immunosuppressant to alleviate this risk.

The trial will be recruiting Japanese residents. If successful, the research team hopes it will become a treatment covered by national health insurance.

Kosei Hasegawa, representative chairman of the Japan Parkinson's Disease Association, told The Japan Times: 'I want the method to be established as a treatment available for anyone as soon as possible.'

SOURCES & REFERENCES
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
12 November 2018 - by Martha Henriques 
A male patient in his fifties has received a stem cell injection into the brain in an early phase trial for Parkinson's disease...
29 October 2018 - by Ewa Zotow 
A novel gene therapy to improve symptoms in Parkinson's disease is being trialled by researchers in London and Paris...
8 October 2018 - by Antony Starza-Allen 
Japan has introduced draft guidelines on genome editing that would permit the use of the approach, including CRISPR/Cas9, in human embryos for research purposes...
9 April 2018 - by Caroline Casey 
A stem cell implant appears to be safe, suggest the results of a clinical trial for the dry form of age-related macular degeneration...
20 November 2017 - by Jenny Sharpe 
Preliminary results from two early stage clinical trials suggest that embryonic stem cells could be used to treat patients with dry age-related macular degeneration...
4 September 2017 - by Caroline Casey 
Neurons derived from human stem cells have successfully been used to treat and relieve symptoms of Parkinson's disease in a primate animal model...
5 June 2017 - by Emma Lamb 
Two teams of doctors in China are to administer embryonic stem cell therapy from fertilised human embryos to treat different degenerative diseases...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.